Can Cancer Cause Blood Clots?

U-M researchers are probing the cause of cancer-related deep vein thrombosis in hopes of developing new therapies.

12:25 PM

Author | Shantell M. Kirkendoll

As patients with cancer fight for their lives, they face a hidden threat for dangerous blood clots.

Surgery and increased bed rest may increase the risk for blood clots. In addition, cancer patients will usually require a peripherally inserted central catheter (or PICC line) to receive IV chemotherapy. PICC lines have been linked with an increase risk for venous thrombosis in the upper extremities.

Unfortunately, anticoagulation therapy is not as effective to prevent blood clots in cancer patients. This has led researchers to examine how cancer appears to tip the body's balance toward pro-clotting.

Cancer patients could be really sick, but if you have DVT in that context, the morbidity and mortality increase.
José Antonio Diaz, M.D.

The mechanisms at work

"We know that patients with cancer have a high risk of developing deep vein thrombosis and DVT recurrence," says José Antonio Diaz, M.D., a vascular surgery researcher in the Conrad Jobst Vascular Research Laboratories at the University of Michigan Cardiovascular Research Center. "We know that there is a relationship between these two diseases, but we hope we can find out why these two diseases are linked. Our main hypotheses are focused around molecules that have been described in both diseases."

Diaz has furthered the understanding of the role galectins play in DVT, clots in the legs that can cause cramping, swelling and a fatal complication known as pulmonary embolism.

Galectins are a family of carbohydrate-binding proteins that are involved in a variety of biological functions, including cell activation and inflammation. Diaz's lab was the first to confirm the location of one of the molecules in that protein family, galectin-3, or gal3, and its role in promoting DVT. The findings were published in the journal Blood.

Galectins are also well-known players in cancer progression and metastasis. Diaz now wants to focus his research on better understanding the link between the two diseases, and how it might be related to the co-occurring molecule.

Treatments in development

Of the patients who develop blood clots, 20 to 30 percent have a history of cancer.

As physicians treat cancer-associated DVT, the approach is usually different. Cancer patients may need longer, more complex anticoagulation therapies to prevent new clots from forming.

"There's something physiologically different about blood clots generated during the cancer experience," suggests Geoffrey Barnes, M.D., a cardiologist and vascular medicine specialist at the University of Michigan Frankel Cardiovascular Center.

Once cancer patients develop a blood clot, they have the highest risk of recurrence, he says.

In Diaz's lab, researchers have developed a new model to study cancer-associated thrombosis, and, using this new tool, are getting preliminary data for future research.

"I hope we are on the right path," says Diaz, a research assistant professor in the Department of Surgery Section of Vascular Surgery. "Cancer patients could be really sick, but if you have DVT in that context, the morbidity and mortality increase. I really hope to help those patients by finding mechanisms that could provide new targets for new treatments." 

More Articles About: Lab Report Coagulation Disorders Blood Disorders (Hematology)
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories cancer cell yellow blue
Health Lab
Potato starch supplements could be solution to bone marrow transplant complications
University of Michigan Health Rogel Cancer Center scientists have found a potential solution for preventing a common and dangerous complication in patients that receive stem cell transplants from a donor’s blood or bone marrow.  
dna strand
Health Lab
Research sheds new light on gene therapy for blood disorders
Research from experts at Michigan Medicine, the Children’s Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy.
Sad young woman face in hand
Health Lab
Study suggests need for iron tests in teen girls & young women
A national study of blood ferritin and hemoglobin levels from tween, teen and young adult females suggests routine screening might be needed for iron deficiency and anemia
microscope cells glioma
Health Lab
Researchers circumvent radiation resistance in subtype of brain tumors
University of Michigan Rogel Cancer Center researchers find ZMYND8 gene plays a critical role in conferring radiation resistance on brain tumors with IDH1 mutation.
tavr stroke blue cardiovascular red inside blue background
Health Lab
Hospitals without highest stroke care designation may miss them after heart procedure
Using stroke as a measure of quality after TAVR could put stroke centers at a disadvantage, the study suggests
cancer cells microscope blue green
Health Lab
Certain gene signaling rewires tumors after immunotherapy
For some patients, immunotherapy furthers tumor progression instead of halting it. What distinguishes those who benefit from those who don’t?